Work Productivity Improvements in Adalimumab-treated Patients with Moderate to Severe Ileocolonic Crohn's Disease: The EXTEND Trial

被引：1
|
作者：
Binion, David [1 ]
Rutgeerts, Paul [2 ]
van Assche, Gert [2 ]
Chen, Naijun [3 ]
Chao, Jingdong [3 ]
Mulani, Parvez [3 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷
关键词：
D O I：
10.14309/00000434-200910003-01238
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1238
引用
收藏
页码：S462 / S462
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Adalimumab in Moderate Compared with Severe Crohn's Disease: Pooled Data from the CHARM and EXTEND Trials
    Colombel, Jean-Frederic
    Sandborn, William
    Castillo, Majin
    Zhou, Qian
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S434 - S435
  • [42] Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's Disease
    Viola, Franca
    Civitelli, Fortunata
    Di Nardo, Giovanni
    Barbato, Maria Beatrice
    Borrelli, Osvaldo
    Oliva, Salvatore
    Conte, Francesca
    Cucchiara, Salvatore
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (10): : 2566 - 2571
  • [43] Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
    Hyams, Jeffrey S.
    Griffiths, Anne
    Markowitz, James
    Baldassano, Robert N.
    Faubion, William A., Jr.
    Colletti, Richard B.
    Dubinsky, Marla
    Kierkus, Jaroslaw
    Rosh, Joel
    Wang, Yaqin
    Huang, Bidan
    Bittle, Barry
    Marshall, Michael
    Lazar, Andreas
    GASTROENTEROLOGY, 2012, 143 (02) : 365 - +
  • [44] Comparison of Clinical Outcomes in Pediatric Patients with Ileocolonic Crohn Disease Treated with Infliximab Versus Adalimumab
    Fanous, Eliana
    Marshanski, Tal
    Tal, Noa
    Matar, Manar
    Weintraub, Yael
    Shamir, Raanan
    Shouval, Dror S.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (03): : 358 - 365
  • [45] Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 study
    Feagan, B. G.
    Reilly, M. C.
    Gerlier, L.
    Brabant, Y.
    Brown, M.
    Schreiber, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (12) : 1276 - 1285
  • [46] Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
    Rutgeerts, Paul
    Van Assche, Gert
    Sandborn, William J.
    Wolf, Douglas C.
    Geboes, Karel
    Colombel, Jean-Frederic
    Reinisch, Walter
    Kumar, Ashish
    Lazar, Andreas
    Camez, Anne
    Lomax, Kathleen G.
    Pollack, Paul F.
    D'Haens, Geert
    GASTROENTEROLOGY, 2012, 142 (05) : 1102 - +
  • [47] The effect of adalimumab on improving work productivity among moderate to severe psoriasis patients
    Kimball, Alexa B.
    Yu, Andrew P.
    Mulani, Parvez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB180 - AB180
  • [48] How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease?
    Ghosh, Subrata
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (10): : 540 - 541
  • [49] Assessment of IMPACT III Emotional and Social Functioning Domain Scores in Adalimumab-Treated Pediatric Patients With Crohn's Disease
    Grant, Amy
    Otley, Anthony R.
    Escher, Johanna
    Hyams, Jeffrey S.
    Maa, Jen-Fue
    Alperovich, Gabriela
    Lazar, Andreas
    Robinson, Anne M.
    Wang, Anthony
    Eichner, Samantha
    GASTROENTEROLOGY, 2016, 150 (04) : S1003 - S1004
  • [50] How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease?
    Subrata Ghosh
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 540 - 541
12345